发明名称 METHOD OF NORMALISING FUNCTIONAL REACTIVITY OF CARDIO-VASCULAR SYSTEM IN CASE OF ARTERIAL HYPERTENSION WITH METABOLIC SYNDROME
摘要 FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to cardiology, and relates normalisation of cardio-vascular system functional reactivity in case of arterial hypertension with metabolic syndrome. For this purpose evaluation of CVS functional reactivity state under psychoemotional load is performed by registration of systolic diastolic, mean dynamic pressure and heart beat rate (HBR). On the basis of said data functional reactivity index (FRI) is determined before and after the load by the formula: FRI=(APav.dyn.x HBR)100 (conv.unit). If FRI is higher than 20 conv.units complex treatment including individually composed hypocaloric diet, which is calculated by formula taking into account sex, age and body weight, reasonably dosed static and dynamic physical loads, as well as introduction of valsartan 80 mg 1 time in the morning and pioglitazone 30 mg 1 time in the morning during not less than 3 months. ^ EFFECT: said complex of medicinal and non-medicinal therapy in combination with empirically selected treatment duration ensure normalisation of CVS functional reactivity in said group of patients due to potentiation of therapeutic effect of certain components of medicinal complex. ^ 2 ex
申请公布号 RU2391082(C1) 申请公布日期 2010.06.10
申请号 RU20090112053 申请日期 2009.04.01
申请人 MEDVEDEV IL'JA NIKOLAEVICH;BESPARTOCHNYJ BORIS DMITRIEVICH 发明人 MEDVEDEV IL'JA NIKOLAEVICH;ZAVALISHINA SVETLANA JUR'EVNA;KRASNOVA EVGENIJA GENNAD'EVNA;DANILENKO OLEG ANATOL'EVICH;MAKSIMOV VLADIMIR IL'ICH;KUMOVA TAT'JANA ALEKSANDROVNA;BESPARTOCHNYJ BORIS DMITRIEVICH
分类号 A23L33/00;A61H1/00;A61K31/41;A61K31/426;A61P5/50;A61P9/12 主分类号 A23L33/00
代理机构 代理人
主权项
地址